Literature DB >> 19655132

Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET.

Martin Bauer1, Rudolf Karch, Friederike Neumann, Aiman Abrahim, Claudia C Wagner, Kurt Kletter, Markus Müller, Markus Zeitlinger, Oliver Langer.   

Abstract

PURPOSE: The aim of this study was to assess the influence of age on the functional activity of the multidrug efflux transporter P-glycoprotein (P-gp) at the human blood-brain barrier.
METHODS: Seven young (mean age: 27 +/- 4 years) and six elderly (mean age: 69 +/- 9 years) healthy volunteers underwent dynamic (R)-[(11)C]verapamil (VPM) positron emission tomography (PET) scans and arterial blood sampling. Parametric distribution volume (DV) images were generated using Logan linearisation, and age groups were compared with statistical parametric mapping (SPM). Brain regions that SPM analysis had shown to be most affected by age were analysed by a region of interest (ROI)-based approach using a maximum probability brain atlas, before and after partial volume correction (PVC).
RESULTS: SPM analysis revealed significant clusters of DV increases in cerebellum, temporal and frontal lobe of elderly compared to younger subjects. In the ROI-based analysis, elderly subjects showed significant DV increases in amygdala (+30%), insula (+26%) and cerebellum (+25%) before PVC, and in insula (+33%) after PVC.
CONCLUSIONS: Increased VPM DV values in the brains of elderly subjects suggest a decrease in cerebral P-gp function with increasing age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655132      PMCID: PMC3689922          DOI: 10.1007/s00228-009-0709-5

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Evaluation of tracer kinetic models for quantification of P-glycoprotein function using (R)-[11C]verapamil and PET.

Authors:  Mark Lubberink; Gert Luurtsema; Bart N M van Berckel; Ronald Boellaard; Rolf Toornvliet; Albert D Windhorst; Eric J F Franssen; Adriaan A Lammertsma
Journal:  J Cereb Blood Flow Metab       Date:  2006-06-07       Impact factor: 6.200

2.  Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.

Authors:  Stina Syvänen; Rujia Xie; Selma Sahin; Margareta Hammarlund-Udenaes
Journal:  Pharm Res       Date:  2006-04-07       Impact factor: 4.200

3.  Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans.

Authors:  Martin Brunner; Oliver Langer; Raute Sunder-Plassmann; Georg Dobrozemsky; Ulrich Müller; Wolfgang Wadsak; Andreas Krcal; Rudolf Karch; Christine Mannhalter; Robert Dudczak; Kurt Kletter; Ilka Steiner; Christoph Baumgartner; Markus Müller
Journal:  Clin Pharmacol Ther       Date:  2005-08       Impact factor: 6.875

Review 4.  Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  Prog Neurobiol       Date:  2005-05       Impact factor: 11.685

5.  Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds.

Authors:  C Dagenais; J Zong; J Ducharme; G M Pollack
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

6.  Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography.

Authors:  Rolf Toornvliet; Bart N M van Berckel; Gert Luurtsema; Mark Lubberink; Albert A Geldof; Tessa M Bosch; Ruud Oerlemans; Adriaan A Lammertsma; Eric J F Franssen
Journal:  Clin Pharmacol Ther       Date:  2006-06       Impact factor: 6.875

7.  Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration.

Authors:  M Eichelbaum; G Mikus; B Vogelgesang
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

8.  Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients.

Authors:  Aiman Abrahim; Gert Luurtsema; Martin Bauer; Rudolf Karch; Mark Lubberink; Ekaterina Pataraia; Christian Joukhadar; Kurt Kletter; Adriaan A Lammertsma; Christoph Baumgartner; Markus Müller; Oliver Langer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-11       Impact factor: 9.236

9.  Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe.

Authors:  Alexander Hammers; Richard Allom; Matthias J Koepp; Samantha L Free; Ralph Myers; Louis Lemieux; Tejal N Mitchell; David J Brooks; John S Duncan
Journal:  Hum Brain Mapp       Date:  2003-08       Impact factor: 5.038

10.  Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil.

Authors:  Oliver Langer; Martin Bauer; Alexander Hammers; Rudolf Karch; Ekaterina Pataraia; Matthias J Koepp; Aiman Abrahim; Gert Luurtsema; Martin Brunner; Raute Sunder-Plassmann; Friedrich Zimprich; Christian Joukhadar; Stephan Gentzsch; Robert Dudczak; Kurt Kletter; Markus Müller; Christoph Baumgartner
Journal:  Epilepsia       Date:  2007-05-01       Impact factor: 5.864

View more
  21 in total

1.  [MUV researcher of the month, March 2015].

Authors:  Martin Bauer
Journal:  Wien Klin Wochenschr       Date:  2015-03       Impact factor: 1.704

Review 2.  The blood brain barrier: Insights from development and ageing.

Authors:  Conor Delaney; Matthew Campbell
Journal:  Tissue Barriers       Date:  2017-09-28

3.  Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and Behavior.

Authors:  Samantha J Hindle; Roeben N Munji; Elena Dolghih; Garrett Gaskins; Souvinh Orng; Hiroshi Ishimoto; Allison Soung; Michael DeSalvo; Toshihiro Kitamoto; Michael J Keiser; Matthew P Jacobson; Richard Daneman; Roland J Bainton
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

Review 4.  PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.

Authors:  Severin Mairinger; Thomas Erker; Markus Muller; Oliver Langer
Journal:  Curr Drug Metab       Date:  2011-10       Impact factor: 3.731

Review 5.  Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier.

Authors:  David S Miller
Journal:  Trends Pharmacol Sci       Date:  2010-04-24       Impact factor: 14.819

6.  A novel positron emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood-brain barrier.

Authors:  Jens P Bankstahl; Marion Bankstahl; Claudia Kuntner; Johann Stanek; Thomas Wanek; Martin Meier; Xiao-Qi Ding; Markus Müller; Oliver Langer; Wolfgang Löscher
Journal:  J Neurosci       Date:  2011-06-15       Impact factor: 6.167

7.  Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET.

Authors:  Viktoria Zoufal; Thomas Wanek; Markus Krohn; Severin Mairinger; Thomas Filip; Michael Sauberer; Johann Stanek; Thomas Pekar; Martin Bauer; Jens Pahnke; Oliver Langer
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-24       Impact factor: 6.200

Review 8.  Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.

Authors:  Stina Syvänen; Jonas Eriksson
Journal:  ACS Chem Neurosci       Date:  2012-12-04       Impact factor: 4.418

Review 9.  Clinical pharmacokinetics of antiretroviral drugs in older persons.

Authors:  John C Schoen; Kristine M Erlandson; Peter L Anderson
Journal:  Expert Opin Drug Metab Toxicol       Date:  2013-03-20       Impact factor: 4.481

10.  Epigenetic Alterations Impact on Antipsychotic Treatment in Elderly Patients.

Authors:  Bryan M McClarty; Daniel W Fisher; Hongxin Dong
Journal:  Curr Treat Options Psychiatry       Date:  2018-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.